Powder: -20°C for 3 years | In solvent: -80°C for 1 year
MK-8745 is a potent and selective Aurora A inhibitor.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
5 mg | In stock | $ 34.00 | |
10 mg | In stock | $ 51.00 | |
25 mg | In stock | $ 91.00 | |
50 mg | In stock | $ 148.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 38.00 |
Description | MK-8745 is a potent and selective Aurora A inhibitor. |
Targets&IC50 | Aurora A:0.6 nM |
In vivo | MK-8745 induces apoptosis in a p53-dependent manner across various cell lines in vitro. Exposure of p53 wild-type cells to MK-8745 leads to the induction of p53 phosphorylation (ser15) and an increase in p53 protein expression. This p53-dependent apoptotic effect of MK-8745 is further confirmed in HCT 116 p53 (-/-) cells transfected with wild-type p53. In non-Hodgkin's lymphoma cell lines, MK-8745 causes cell cycle arrest at the G2/M phase with the accumulation of tetraploid nuclei, followed by cell death. Treatment with MK-8745 induces p21 (waf1/cip1) and CycB1, indicating cell cycle arrest and an increased population of cells in the G2/M phase. Additionally, MK-8745 treatment leads to the rapid degradation of Aurora-A substrates (TACC3, Eg5, and TPX2) following the reduction of phospho-Aurora-A. |
Molecular Weight | 431.91 |
Formula | C20H19ClFN5OS |
CAS No. | 885325-71-3 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
H2O: < 1 mg/mL (insoluble or slightly soluble)
Ethanol: 1 mg/mL (2.31 mM)
DMSO: 80 mg/mL (185.2 mM)
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
MK-8745 885325-71-3 Apoptosis Cell Cycle/Checkpoint Chromatin/Epigenetic Aurora Kinase MK8745 Inhibitor inhibit MK 8745 inhibitor